SLA 1.12% $4.50 silk laser australia limited

might run back over 20 after meeting, page-51

  1. 4,583 Posts.
    lightbulb Created with Sketch. 41
    trent26

    Yes, I do agree that sales of Ropren, as projected and if realised, would be a company maker.

    I think SLA have marketed BioA 320 wrongly, by inflating what is merely an L registered health aid into a practitioner only drug.

    They are indulging in snobbish dreams about its medical mightiness, and at the same time boasting about their loyal practitioners - who as we have seen don't count for much in terms of sales.

    BioA 320 should be on pharmacy and supermarket shelves alongside Blackmore's products - and alongside other supermarket and pharmacy medicines that are potentially far more potent to the human system, i.e. R registered paracetamol.

    I have banged on about this before. I found that a course of BioA 320 helped my stomach. Why can't I find it on the shelves of pharmacies and supermarkets?

    Yes, I know I can buy it on the internet. But how many potential customers know of the product? Exposure is part of selling. Why put a practitioner between me and BioA 320. I want to go directly to my god, not deal through a priest.
 
watchlist Created with Sketch. Add SLA (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.